Title for MeetingAbstracts
Alphabetical listing of titles
Can nelfinavir substitute for other protease inhibitor(s) in persons with plasma HIV-1 RNA below 500 copies/ml before the substitution?
Can new treatment strategies which reduce restenosis rates following PTCA save money?.
Can newer therapies be cost-neutral or cost-saving in myocardial infarction patients?.
Can Nucleoside Analogues Work against HTLV-I or HTLV-II in Infected Carriers?
Can nursing homes offer more quality for less cost? Evidence from New York State.
Can one organize low- and middle class commercial sex workers (CSW) in Kathmandu?
Can Patients with Serious Mental Illness Report Their Symptoms on a Computerized Assessment?
Can PCP prophylaxis be safely discontinued among clinically improving HIV patients?
Can peer education be relied upon as an effective tool in promoting health seeking behaviour among peers at workplaces.
Can peer education have an impact on partner referral fo sexually transmitted diseases management and voluntary counselling and testing.
Can Persistent Chlamydia pneumoniae Infection Cause a Naso-Pharyngo-Bronchial Syndrome?
Can Pharmacogenomics Improve Drug Safety?
Can Pharmacy Data Identify Severely Mentally Ill Patients Needing Help with Adherence?
Can population differences in Mwanza, Rakai and Masaka explain the contrasting outcomes of the intervention trials? A modelling study.
Can Post-Influenza Complications Among the Elderly Be Predicted and Prevented?
Can prescribing policy influence HIV risk behaviour?
Can Procalcitonin Measurement Contribute to Reduce Unnecessary Antibiotic Treatments in Viral Meningitis in Children?
Can prophylaxis for PCP and cerebral toxoplasmosis be safely discontinued in HIV-infected patients successfully treated with HAART?, The EuroSIDA Study.
Can pulse-oximetry screen children for obstructive sleep apnea (OSA) ?
Can Religious Leaders (RLs) play any role in HIV interventions at the conservative rural settings in Bangladesh?
Can research make a difference in clinical practice treating major depression?.
Can responsible and aggressive technology assessment be compatible with fostering innovation, development and diffusion?.
Can rHuGM-CSF help treating drug-resistant cryptosporidiosis in AIDS?
Can ritonavir (RTV) once daily boost saquinavir (SQV) twice daily? A pilot study.
Can Russia be classified as pattern 3 area of HIV-infection?
Can saliva be used as an alternative specimen for therapeutic drug monitoring (TDM) of nevirapine (NVP) in HIV-1-infected patients?
Can secondary pneumocystis carinii pneumonia (PCP) prophylaxis be discontinued in HIV-infected patients treated with highly active antiretroviral therapy(HAART)?
Can semen quality and mitochondrial DNA deletions be used as a marker of nucleoside analogue toxicity?
Can shared care deliver better outcomes for patients undergoing total hip replacement?
Can some skin diseases serve as sentinel signs for HIV epidemic in Rwanda?